These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32722110)

  • 1. On the True Number of COVID-19 Infections: Effect of Sensitivity, Specificity and Number of Tests on Prevalence Ratio Estimation.
    Altman E; Mounir I; Najid FZ; Perlaza SM
    Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32722110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 prevalence estimation by random sampling in population - optimal sample pooling under varying assumptions about true prevalence.
    Brynildsrud O
    BMC Med Res Methodol; 2020 Jul; 20(1):196. PubMed ID: 32703158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
    Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
    Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol.
    Guerriero M; Bisoffi Z; Poli A; Micheletto C; Pomari C
    BMJ Open; 2020 Oct; 10(10):e040036. PubMed ID: 33028562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers.
    Kumleben N; Bhopal R; Czypionka T; Gruer L; Kock R; Stebbing J; Stigler FL
    Public Health; 2020 Aug; 185():88-90. PubMed ID: 32590234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
    Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
    Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooling of coronavirus tests under unknown prevalence.
    Pikovski A; Bentele K
    Epidemiol Infect; 2020 Aug; 148():e183. PubMed ID: 32758313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department.
    Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Quarto M; Procacci V; Chironna M
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32906596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Performance of SARS-CoV-2 Molecular Tests.
    Green DA; Zucker J; Westblade LF; Whittier S; Rennert H; Velu P; Craney A; Cushing M; Liu D; Sobieszczyk ME; Boehme AK; Sepulveda JL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples.
    Dao Thi VL; Herbst K; Boerner K; Meurer M; Kremer LP; Kirrmaier D; Freistaedter A; Papagiannidis D; Galmozzi C; Stanifer ML; Boulant S; Klein S; Chlanda P; Khalid D; Barreto Miranda I; Schnitzler P; Kräusslich HG; Knop M; Anders S
    Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32719001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Serology: Much Hype, Little Data.
    Farnsworth CW; Anderson NW
    Clin Chem; 2020 Jul; 66(7):875-877. PubMed ID: 32343775
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of SARS-CoV-2 in nasal swabs using MALDI-MS.
    Nachtigall FM; Pereira A; Trofymchuk OS; Santos LS
    Nat Biotechnol; 2020 Oct; 38(10):1168-1173. PubMed ID: 32733106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody tests for COVID-19: What the results tell us].
    Horvath K; Semlitsch T; Jeitler K; Krause R; Siebenhofer A
    Z Evid Fortbild Qual Gesundhwes; 2020 Aug; 153():54-59. PubMed ID: 32419875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.